Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
Annals of Clinical and Translational Neurology · 2026-11 · 13 (11) · 2188-2205
DOI: 10.1002/acn3.70487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 11.10.2026. Verfasst von Osman Corbali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Diabetes Complications. Die Arbeit nennt 282 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking clear VaD or AD features, diabetes may act as a primary driver of neurodegeneration. Mechanistically, DACI can be conceptualized as a neurovascular‐metabolic disorder characterized by disruption of the neurovascular unit, impaired cerebral glucose metabolism, brain insulin resistance, and chronic neuroinflammation, contributing to small vessel disease, regional brain atrophy, and accelerated brain aging. In this narrative review, we synthesize current evidence on the clinical and imaging features of DACI, outline key mechanistic pathways linking diabetes to neurodegeneration, and discuss emerging therapeutic strategies, including GLP‐1 receptor agonists and SGLT2 inhibitors, with potential neuroprotective effects. Greater recognition of DACI as a neurovascular‐metabolic entity may facilitate earlier identification, inform biomarker development, and guide future trials aimed at preserving cognitive function in individuals with diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Medical College of Georgia, Augusta University, Augusta, Georgia, USA.
- Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Emory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University, Atlanta, Georgia, USA.
- Hubert Department of Global Health, Emory University, Atlanta, Georgia, USA.
ORCID-Profile: Osman Corbali, Allan I Levey
Zitieren
APA
Corbali, O., Menon, P., Corbali, H. I., Jagannathan, R., & Levey, A. I. (2026). Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies. Annals of Clinical and Translational Neurology, 13(11), 2188-2205. https://doi.org/10.1002/acn3.70487
Vancouver
Corbali O, Menon P, Corbali HI, Jagannathan R, Levey AI. Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies. Annals of Clinical and Translational Neurology. 2026;13(11):2188-2205. doi:10.1002/acn3.70487
BibTeX
@article{Corbali2026,
author = {Corbali, Osman and Menon, Priyanka and Corbali, Halil I and Jagannathan, Ram and Levey, Allan I},
title = {Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
volume = {13},
number = {11},
pages = {2188--2205},
doi = {10.1002/acn3.70487}
}
EUVIMED